US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 11, 2019 (7 years ago)

Estriol

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug: Supplier indicated assay results did not meet specifications.

What was recalled

Estriol [(16a, 17B)-Estra-1,3,5(10)-triene-3,16,17-triol; Oestriol] Micronized, USP, CAS 50-27-1, packaged in a) 1 G glass bottles, b) 5 G glass bottles, c) 25 G glass bottles, d) 100 G glass bottles, e) 500 G glass bottles, and f) 1 KG plastic bottles, Rx Only, Spectrum Chemical Mfg Corp., Gardena, CA 90248.

Recalling firm
Spectrum Laboratory Products
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0628-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Estriol recalls

See all
Class II · Moderate risk Terminated

Estriol 1mg/gm

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1186-2022
Class II · Moderate risk Terminated

Estriol 1mg/gm

Reason Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Wedgewood Village Pharmacy, LLC D-1185-2022
Class II · Moderate risk Terminated

Estriol 8 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1421-2020
Class II · Moderate risk Terminated

Estriol 6 mg Capsule

Reason Lack of Processing Controls (lack of assurance of conformity to specifications).

MasterPharm LLC D-1420-2020